Annovis Bio Stock Rockets As Alzheimer’s Drug Tops Biogen, Cassava Sciences

Annovis Bio said Friday its experimental Alzheimer’s and Parkinson’s treatment improved cognition in less than a month and ANVS stock roared higher.
Read More